Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 20, 2011 - Issue 10
Submit an article Journal homepage
417
Views
6
CrossRef citations to date
0
Altmetric
Discontinued Drug Perspective

Discontinued drugs in 2010: cardiovascular drugs

Hong-ping Zhao Center for Instrumental Analysis, China Pharmaceutical University, Nanjing, Key Laboratory of Drug Quality Control & Pharmacovigilance, Ministry of Education, Jiangsu 210009, People's Republic of China+86 25 8327 1180; +86 25 8327 1335; [email protected]
,
Xu-song Zhang Center for Instrumental Analysis, China Pharmaceutical University, Nanjing, Key Laboratory of Drug Quality Control & Pharmacovigilance, Ministry of Education, Jiangsu 210009, People's Republic of China+86 25 8327 1180; +86 25 8327 1335; [email protected]
&
Bing-ren Xiang Center for Instrumental Analysis, China Pharmaceutical University, Nanjing, Key Laboratory of Drug Quality Control & Pharmacovigilance, Ministry of Education, Jiangsu 210009, People's Republic of China+86 25 8327 1180; +86 25 8327 1335; [email protected]
Pages 1311-1325 | Published online: 26 Aug 2011

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Hong-ping Zhao & Bing-ren Xiang. (2015) Discontinued cardiovascular drugs in 2013 and 2014. Expert Opinion on Investigational Drugs 24:8, pages 1083-1092.
Read now
Hong-Ping Zhao, Hong-Min Jiang & Bing-Ren Xiang. (2013) Discontinued drugs in 2012: cardiovascular drugs. Expert Opinion on Investigational Drugs 22:11, pages 1437-1451.
Read now
Hong-Ping Zhao, Hong-Min Jiang & Bing-Ren Xiang. (2012) Discontinued drugs in 2011: cardiovascular drugs. Expert Opinion on Investigational Drugs 21:10, pages 1449-1462.
Read now

Articles from other publishers (3)

Norbert Jost, Torsten Christ & János Magyar. (2021) New Strategies for the Treatment of Atrial Fibrillation. Pharmaceuticals 14:9, pages 926.
Crossref
Chunying Luo, Maxwell Ampomah-Wireko, Huanhuan Wang, Chunli Wu, Qing Wang, Hui Zhang & Yaquan Cao. (2021) Isoquinolines: Important Cores in Many Marketed and Clinical Drugs. Anti-Cancer Agents in Medicinal Chemistry 21:7, pages 811-824.
Crossref
Fan Hong, Pengfei Xu & Yonggong Zhai. (2018) The Opportunities and Challenges of Peroxisome Proliferator-Activated Receptors Ligands in Clinical Drug Discovery and Development. International Journal of Molecular Sciences 19:8, pages 2189.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.